Kim T - Search Results

1

Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation.

Kim EY, Lee SH, Kim A, Kim T, Chang YS. Kim EY, et al. Among authors: kim a, kim t. J Cancer. 2019 Aug 29;10(22):5549-5556. doi: 10.7150/jca.32897. eCollection 2019. J Cancer. 2019. PMID: 31632498 Free PMC article.

2

Fully Solution-Processed and Foldable Metal-Oxide Thin-Film Transistor.

Lee SJ, Ko J, Nam KH, Kim T, Lee SH, Kim JH, Chae GS, Han H, Kim YS, Myoung JM. Lee SJ, et al. Among authors: kim t, kim ys, kim jh. ACS Appl Mater Interfaces. 2016 May 25;8(20):12894-900. doi: 10.1021/acsami.6b00950. Epub 2016 May 10. ACS Appl Mater Interfaces. 2016. PMID: 27120010

3

Methionyl-tRNA Synthetase is a Useful Diagnostic Marker for Lymph Node Metastasis in Non-Small Cell Lung Cancer.

Lee JM, Kim T, Kim EY, Kim A, Lee DK, Kwon NH, Kim S, Chang YS. Lee JM, et al. Among authors: kim ey, kim a, kim t, kim s. Yonsei Med J. 2019 Nov;60(11):1005-1012. doi: 10.3349/ymj.2019.60.11.1005. Yonsei Med J. 2019. PMID: 31637881 Free PMC article.

4

Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma.

Kim T, Kim EY, Lee SH, Kwon DS, Kim A, Chang YS. Kim T, et al. Among authors: kim ey, kim a. Thorac Cancer. 2019 Dec;10(12):2267-2273. doi: 10.1111/1759-7714.13219. Epub 2019 Oct 24. Thorac Cancer. 2019. PMID: 31647198 Free PMC article.

5

Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation-Positive Lung Adenocarcinoma.

Kim T, Cha YJ, Chang YS. Kim T, et al. Tuberc Respir Dis (Seoul). 2020 Jan;83(1):51-60. doi: 10.4046/trd.2019.0026. Tuberc Respir Dis (Seoul). 2020. PMID: 31905432 Free PMC article.

6

Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.

Lee SH, Kim EY, Kim T, Chang YS. Lee SH, et al. Among authors: kim ey, kim t. Respir Res. 2020 Jun 9;21(1):142. doi: 10.1186/s12931-020-01408-x. Respir Res. 2020. PMID: 32517757 Free PMC article.

7

Prediction model for hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitors.

Choi YJ, Kim T, Kim EY, Lee SH, Kwon DS, Chang YS. Choi YJ, et al. Among authors: kim ey, kim t. Thorac Cancer. 2020 Oct;11(10):2793-2803. doi: 10.1111/1759-7714.13594. Epub 2020 Aug 11. Thorac Cancer. 2020. PMID: 32779394 Free PMC article.

8

Reactive oxygen species modulator 1 expression predicts lymph node metastasis and survival in early-stage non-small cell lung cancer.

Kim T, Cha YJ, Park JH, Kim A, Choi YJ, Park HJ. Kim T, et al. Among authors: kim a. PLoS One. 2020 Dec 1;15(12):e0239670. doi: 10.1371/journal.pone.0239670. eCollection 2020. PLoS One. 2020. PMID: 33259495 Free PMC article.

9

Methionyl-tRNA synthetase and aminoacyl-tRNA synthetases interacting multi-functional protein-lacking exon 2 as potential diagnostic biomarkers for lung cancer.

Kim T, Lee K, Nahm JH, Kim EY, Lee SH, Chang YS. Kim T, et al. Among authors: kim ey. Am J Cancer Res. 2021 Jun 15;11(6):3135-3144. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249450 Free PMC article.

10

Outstanding Characteristics of Birt-Hogg-Dube Syndrome in Korea.

Park HJ, Choi YJ, Park CH, Kim TH, Lee SS, Moon DH, Lee KA, Lee SE, Park MS, Kim SY, Chang YS, Lee SJ, Jung JY, Lee JH, Lee SH, Kim T, Kim SR, Kim K, Byun MK. Park HJ, et al. Among authors: kim sr, kim th, kim t, kim sy, kim k. Diagnostics (Basel). 2023 Jun 13;13(12):2047. doi: 10.3390/diagnostics13122047. Diagnostics (Basel). 2023. PMID: 37370942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,433 results

Search Page

Filters